ArticlePharmaceuticals (Basel, Switzerland)2026

Effectiveness and Safety of Rituximab in Patients with Refractory Juvenile Idiopathic Arthritis: A Tertiary Center Experience.

Ekaterina I Alexeeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.